Physician profile
Robert Porter Smith
NPI 1134190416
$521.75
in general payments reported to CMS, 2019-2025
8 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.22 · 2020: $166 · 2021: $32.83 · 2022: $26.72 · 2023: $33.39 · 2024: $125 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $199.62 | 2022-2025 | Alphagan P, Lumigan |
| Alcon Vision LLC | $113.17 | 2020-2025 | Rocklatan, Ilux |
| Aerie Pharmaceuticals, INC. | $91.55 | 2019-2020 | |
| Allergan, INC. | $38.86 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $24.84 | 2024 | Xdemvy |
| Astellas Pharma US INC | $21.67 | 2025 | Izervay |
| Glaukos Corporation | $17.58 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.